Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Circulating tumor cells (CTCs) in patients with metastatic castration resistant prostate cancer (mCRPC) treated with olaparib plus <sup>177</sup>lutetium-prostate specific membrane antigen-617 (<sup>177</sup>Lu-PSMA-617) in the LuPARP trial.
Anis Hamid, Santosh Gupta, Shivakumar Keerthikumar, Anupama Pasam, Megan Crumbaker, Anthony M. Joshua, Ernest W.N. Lam, Rick Wenstrup, Louise Emmett, David L. Goode, Michael S. Hofman, Shahneen Sandhu (2023). Circulating tumor cells (CTCs) in patients with metastatic castration resistant prostate cancer (mCRPC) treated with olaparib plus <sup>177</sup>lutetium-prostate specific membrane antigen-617 (<sup>177</sup>Lu-PSMA-617) in the LuPARP trial.. , 41(16_suppl), DOI: https://doi.org/10.1200/jco.2023.41.16_suppl.5064.
Article172 days agoPerformance of a blood-based liquid biopsy test to detect PSMA expression on circulating tumor cells in men with metastatic prostate cancer.
Santosh Gupta, Anis Hamid, Luisa Fernandez, Anupama Pasam, Ernest W.N. Lam, Alisa Tubbs, David Bourdon, Louise Emmett, Anthony M. Joshua, Michael S. Hofman, Rick Wenstrup, Shahneen Sandhu (2023). Performance of a blood-based liquid biopsy test to detect PSMA expression on circulating tumor cells in men with metastatic prostate cancer.. , 41(6_suppl), DOI: https://doi.org/10.1200/jco.2023.41.6_suppl.256.
Article172 days ago